4//SEC Filing
B Capital Global Growth III, L.P. 4
Accession 0000950170-25-098549
CIK 0001794546other
Filed
Jul 23, 8:00 PM ET
Accepted
Jul 24, 8:51 PM ET
Size
29.4 KB
Accession
0000950170-25-098549
Insider Transaction Report
Form 4
CARLSMED, INC.CARL
B CAPITAL GROUP MANAGEMENT, L.P.
10% Owner
Transactions
- Conversion
Series B Preferred Stock
2025-07-24−1,445,020→ 0 total(indirect: By B Capital Healthcare I, L.P.)→ Common Stock (1,445,020 underlying) - Conversion
Series C Preferred Stock
2025-07-24−931,452→ 0 total(indirect: By Hornet Co-Invest, L.P.)→ Common Stock (931,452 underlying) - Conversion
Common Stock
2025-07-24+2,376,472→ 2,376,472 total(indirect: By B Capital Healthcare I, L.P.) - Conversion
Series B Preferred Stock
2025-07-24−1,445,020→ 0 total(indirect: By B Capital Global Growth III, L.P.)→ Common Stock (1,445,020 underlying) - Conversion
Series C Preferred Stock
2025-07-24−931,452→ 0 total(indirect: By B Capital Healthcare I, L.P.)→ Common Stock (931,452 underlying) - Conversion
Common Stock
2025-07-24+3,680,506→ 3,680,506 total(indirect: By B Capital Global Growth III, L.P.) - Purchase
Common Stock
2025-07-24$15.00/sh+1,333,333$19,999,995→ 5,013,839 total(indirect: By B Capital Global Growth III, L.P.) - Conversion
Common Stock
2025-07-24+931,452→ 931,452 total(indirect: By Hornet Co-Invest, L.P.) - Conversion
Series C Preferred Stock
2025-07-24−2,235,486→ 0 total(indirect: By B Capital Global Growth III, L.P.)→ Common Stock (2,235,486 underlying)
B Capital Global Growth III, L.P.
10% Owner
Transactions
- Conversion
Common Stock
2025-07-24+2,376,472→ 2,376,472 total(indirect: By B Capital Healthcare I, L.P.) - Conversion
Series C Preferred Stock
2025-07-24−931,452→ 0 total(indirect: By Hornet Co-Invest, L.P.)→ Common Stock (931,452 underlying) - Conversion
Common Stock
2025-07-24+3,680,506→ 3,680,506 total(indirect: By B Capital Global Growth III, L.P.) - Purchase
Common Stock
2025-07-24$15.00/sh+1,333,333$19,999,995→ 5,013,839 total(indirect: By B Capital Global Growth III, L.P.) - Conversion
Series B Preferred Stock
2025-07-24−1,445,020→ 0 total(indirect: By B Capital Global Growth III, L.P.)→ Common Stock (1,445,020 underlying) - Conversion
Series B Preferred Stock
2025-07-24−1,445,020→ 0 total(indirect: By B Capital Healthcare I, L.P.)→ Common Stock (1,445,020 underlying) - Conversion
Common Stock
2025-07-24+931,452→ 931,452 total(indirect: By Hornet Co-Invest, L.P.) - Conversion
Series C Preferred Stock
2025-07-24−2,235,486→ 0 total(indirect: By B Capital Global Growth III, L.P.)→ Common Stock (2,235,486 underlying) - Conversion
Series C Preferred Stock
2025-07-24−931,452→ 0 total(indirect: By B Capital Healthcare I, L.P.)→ Common Stock (931,452 underlying)
B Capital Healthcare I, L.P.
10% Owner
Transactions
- Conversion
Common Stock
2025-07-24+2,376,472→ 2,376,472 total(indirect: By B Capital Healthcare I, L.P.) - Conversion
Series C Preferred Stock
2025-07-24−931,452→ 0 total(indirect: By Hornet Co-Invest, L.P.)→ Common Stock (931,452 underlying) - Conversion
Common Stock
2025-07-24+931,452→ 931,452 total(indirect: By Hornet Co-Invest, L.P.) - Purchase
Common Stock
2025-07-24$15.00/sh+1,333,333$19,999,995→ 5,013,839 total(indirect: By B Capital Global Growth III, L.P.) - Conversion
Series C Preferred Stock
2025-07-24−931,452→ 0 total(indirect: By B Capital Healthcare I, L.P.)→ Common Stock (931,452 underlying) - Conversion
Common Stock
2025-07-24+3,680,506→ 3,680,506 total(indirect: By B Capital Global Growth III, L.P.) - Conversion
Series B Preferred Stock
2025-07-24−1,445,020→ 0 total(indirect: By B Capital Global Growth III, L.P.)→ Common Stock (1,445,020 underlying) - Conversion
Series B Preferred Stock
2025-07-24−1,445,020→ 0 total(indirect: By B Capital Healthcare I, L.P.)→ Common Stock (1,445,020 underlying) - Conversion
Series C Preferred Stock
2025-07-24−2,235,486→ 0 total(indirect: By B Capital Global Growth III, L.P.)→ Common Stock (2,235,486 underlying)
Hornet Co-Invest Investors, Ltd.
10% Owner
Transactions
- Conversion
Series C Preferred Stock
2025-07-24−2,235,486→ 0 total(indirect: By B Capital Global Growth III, L.P.)→ Common Stock (2,235,486 underlying) - Conversion
Series C Preferred Stock
2025-07-24−931,452→ 0 total(indirect: By Hornet Co-Invest, L.P.)→ Common Stock (931,452 underlying) - Conversion
Common Stock
2025-07-24+3,680,506→ 3,680,506 total(indirect: By B Capital Global Growth III, L.P.) - Conversion
Common Stock
2025-07-24+931,452→ 931,452 total(indirect: By Hornet Co-Invest, L.P.) - Conversion
Series C Preferred Stock
2025-07-24−931,452→ 0 total(indirect: By B Capital Healthcare I, L.P.)→ Common Stock (931,452 underlying) - Purchase
Common Stock
2025-07-24$15.00/sh+1,333,333$19,999,995→ 5,013,839 total(indirect: By B Capital Global Growth III, L.P.) - Conversion
Common Stock
2025-07-24+2,376,472→ 2,376,472 total(indirect: By B Capital Healthcare I, L.P.) - Conversion
Series B Preferred Stock
2025-07-24−1,445,020→ 0 total(indirect: By B Capital Global Growth III, L.P.)→ Common Stock (1,445,020 underlying) - Conversion
Series B Preferred Stock
2025-07-24−1,445,020→ 0 total(indirect: By B Capital Healthcare I, L.P.)→ Common Stock (1,445,020 underlying)
Hornet Co-Invest, LP
10% Owner
Transactions
- Purchase
Common Stock
2025-07-24$15.00/sh+1,333,333$19,999,995→ 5,013,839 total(indirect: By B Capital Global Growth III, L.P.) - Conversion
Common Stock
2025-07-24+931,452→ 931,452 total(indirect: By Hornet Co-Invest, L.P.) - Conversion
Series C Preferred Stock
2025-07-24−2,235,486→ 0 total(indirect: By B Capital Global Growth III, L.P.)→ Common Stock (2,235,486 underlying) - Conversion
Series C Preferred Stock
2025-07-24−931,452→ 0 total(indirect: By B Capital Healthcare I, L.P.)→ Common Stock (931,452 underlying) - Conversion
Series B Preferred Stock
2025-07-24−1,445,020→ 0 total(indirect: By B Capital Healthcare I, L.P.)→ Common Stock (1,445,020 underlying) - Conversion
Common Stock
2025-07-24+3,680,506→ 3,680,506 total(indirect: By B Capital Global Growth III, L.P.) - Conversion
Series B Preferred Stock
2025-07-24−1,445,020→ 0 total(indirect: By B Capital Global Growth III, L.P.)→ Common Stock (1,445,020 underlying) - Conversion
Common Stock
2025-07-24+2,376,472→ 2,376,472 total(indirect: By B Capital Healthcare I, L.P.) - Conversion
Series C Preferred Stock
2025-07-24−931,452→ 0 total(indirect: By Hornet Co-Invest, L.P.)→ Common Stock (931,452 underlying)
Footnotes (5)
- [F1]Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock (collectively, the "Preferred Stock") automatically converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering without payment of additional consideration. The Preferred Stock had no expiration date.
- [F2]Shares held by B Capital Global Growth III, L.P.
- [F3]Shares held by B Capital Healthcare I, L.P.
- [F4]Shares held by Hornet Co-Invest, L.P.
- [F5]B Capital Group Management, LP is the manager of B Capital Global Growth III, L.P. and B Capital Healthcare I, L.P. Hornet-Co-Invest Investors, Ltd. is the ultimate general partner of Hornet Co-Invest, L.P. (Hornet Co-Invest, L.P., together with B Capital Healthcare I, L.P., and B Capital Global Growth III, L.P., "B Capital"). Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Exchange Act, except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
Documents
Issuer
CARLSMED, INC.
CIK 0001794546
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001911138
Filing Metadata
- Form type
- 4
- Filed
- Jul 23, 8:00 PM ET
- Accepted
- Jul 24, 8:51 PM ET
- Size
- 29.4 KB